Chapter 1. Artificial Tears Market – Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Artificial Tears Market – Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
          2.3.2    Impact on Supply – Demand
Chapter 3. Artificial Tears Market – Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Artificial Tears Market - Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
          4.4.1     Bargaining Power of Suppliers
          4.4.2     Bargaining Powers of Customers
          4.4.3    Threat of New Entrants
          4.4.4    .Rivalry among Existing Players
          4.4.5    Threat of Substitutes
Chapter 5. Artificial Tears Market - Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Artificial Tears Market - By Type
6.1    Glycerin Derived Tears
6.2    Cellulose Derived Tears
6.3    Polyethylene glycol & Propylene glycol-based artificial tears
6.4    Sodium Hyaluronate Based Tears
6.5    Oil-based Emulsion Tears
6.6    Others
Chapter 7. Artificial Tears Market - By Delivery Mode
7.1    Eye Drops
7.2    Ointments
Chapter 8. Artificial Tears Market  - By Application
8.1    Dry Eyes Treatment
8.2    Contact Lenses Moisture
Chapter 9. Artificial Tears Market - By End-User Age Groups
9.1    20 to 40 Years
9.2    41 to 60 Years
9.3    Above 60 Years
Chapter 10. Artificial Tears Market – By Region
10.1    North America
10.2    Europe
10.3    Asia-Pacific
10.4    Latin America
10.5    The Middle East
10.6    Africa
Chapter 11. Artificial Tears Market – Key players
11.1    Johnson & Johnson (the U.S.)
11.2     Bausch + Lomb (the U.S.)
11.3    Novartis International AG (Switzerland)
11.4    Akorn Inc. (the U.S.)
11.5    Rohto Pharmaceutical Co., Ltd. (Japan)
11.6    Allergan plc (Republic of Ireland)
11.7    VISUfarma (Netherlands)
11.8    Otsuka Pharmaceutical Co., Ltd. (Japan)
11.9    NovaMedica LLC (Russia)
11.10    OASIS Medical, Inc. (the U.S.)
11.11    ENTOD Research Cell UK Ltd (the U.K.)
11.12    Santen Pharmaceutical Co., Ltd. (Japan)
11.13    Abbott Medical Optics Inc. (the U.S.)